HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Pheniramine

HCID 4761
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
86-21-5
Standard SMILES
CN(C)CCC(c1ccccc1)c1ccccn1
InChIKey
IJHNSHDBIRRJRN-UHFFFAOYSA-N
Molecular formula
C16H20N2
Average molar mass
240.34 g/mol
Monoisotopic mass
240.16264865

Overview

N,N-dimethyl-3-phenyl-3-(2-pyridinyl)-1-propanamine is a member of pyridines and a tertiary amino compound.

Names & identifiers

Preferred name
Pheniramine
IUPAC
N,N-dimethyl-3-phenyl-3-pyridin-2-ylpropan-1-amine
English name
Pheniramine
Molecular formula
C16H20N2
Molecular weight
240.34

Names & synonyms

pheniramineProphenpyridamineTripotonPyriton86-21-5PropheniramineFeniraminaPheniraminumdimethyl[3-phenyl-3-(pyridin-2-yl)propyl]amine2-(alpha-(2-Dimethylaminoethyl)benzyl)pyridineNSC-47965134FM9ZZ6M
Show more names
AVILMetronTrimetonFeniramineNCI-C60695PHENIRAMINE BASE
2-Pyridinepropanamine, N,N-dimethyl-gamma-phenyl-DTXSID0023454Pyridine, 2-(alpha-(2-(dimethylamino)ethyl)benzyl)-dimethyl(3-phenyl-3-(pyridin-2-yl)propyl)amine(+-)-PheniramineRefChem:860603DTXCID203454D04AA16

Database identifiers

CAS
86-21-5
PubChem CID
4761
DTXSID
DTXSID0023454
ChEMBL
CHEMBL1193
ChEBI
CHEBI:91591
UNII
134FM9ZZ6M
EC Number
201-656-2
Nikkaji
J4.935B

Properties

Computed structural properties

XLogP
2.8
Topological polar surface area
16.1 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
2
Rotatable bonds
5
Heavy atoms
18
Formal charge
0
Complexity
221

Experimental & physicochemical properties

DrugsPharmaceuticals -> Used in Switzerland
Solubility3.77e-01 g/L
Animal DrugsPharmaceuticals -> Animal Drugs -> Approved in Taiwan
Boiling Point175.00 °C. @ 25.00 mm Hg
Melting Point< 25 °C
Physical DescriptionSolid
Collision Cross Section156.75 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physicochemical properties

Melting point
108 °C · 108 °C
Boiling point
13 · bp13 181°; bp2 142°; bp0.5 135°
Density
1.0081 · 1.0081
refractive index
25 · nD25 1.5519 to 1.5521
Flash point
9.7 °C · 9.7 °C - closed cup
storage temp.
-20 °C · -20°C
solubility
Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
form
powder to crystal
pka
4.03 · pKa 4.03± 0.08;9.32± 0.06(H2O,t undefined,I=0.30(NaCl)) (Uncertain)
color
White to Almost white
Major Application
clinical testing
InChI
1S/C16H20N2/c1-18(2)13-11-15(14-8-4-3-5-9-14)16-10-6-7-12-17-16/h3-10,12,15H,11,13H2,1-2H3
InChIKey
IJHNSHDBIRRJRN-UHFFFAOYSA-N
SMILES
CN(C)CCC(c1ccccc1)c2ccccn2
CAS DataBase Reference
86 · 86-21-5(CAS DataBase Reference)
FDA UNII
134 FM9ZZ6M · 134FM9ZZ6M
NIST Chemistry Reference
2 · Pyridine, 2[alpha-(2-dimethyl aminoethyl)benzyl](86-21-5)
ATC code
4 AA16,R06AB05 · D04AA16,R06AB05
Comptox DTXSID
23454 · DTXSID0023454
UNSPSC Code
41116107 · 41116107
NACRES
24 · NA.24
Symbol(GHS)
2 · GHS02,GHS06,GHS08
Signal word
Danger
Hazard statements
225 · H225-H301+H311+H331-H370
Precautionary statements
210 · P210-P260-P280-P301+P310-P311
target organs
Eyes
Hazard Codes
F,T
Risk Statements
11 · 11-23/24/25-39/23/24/25
Safety Statements
16 · 16-36/37-45
RIDADR
1230 · UN1230 - class 3 - PG 2 - Methanol, solution
WGK Germany
1 · 1
Storage Class
3 · 3 - Flammable liquids
Hazard Classifications
3 DermalAcute · Acute Tox. 3 DermalAcute Tox. 3 InhalationAcute Tox. 3 OralFlam. Liq. 2STOT SE 1

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H300 (97.5%): Fatal if swallowed [Danger Acute toxicity, oral]

P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 40 reports by companies from 2 notifications to the ECHA C&L Inventory.

Hazard information

Regulatory Information2-Pyridinepropanamine, N,N-dimethyl-.gamma.-phenyl-: Does not have an individual approval but may be used under an appropriate group standard
Other Safety InformationIMAP assessments - 2-Pyridinepropanamine, N,N-dimethyl-.gamma.-phenyl-: Human health tier I assessment
Hazard Classes and CategoriesAcute Tox. 2 (97.5%)

Toxicology

Effects During Pregnancy and Lactation◈ What is pheniramine?

Safety data

wgk
1
ridadr
UN1230 - class 3 - PG 2 - Methanol, solution
risk_code
11-23/24/25-39/23/24/25
Signal word
Danger
Symbol(GHS)
GHS02,GHS06,GHS08
hazard_code
F,T
safety_code
16-36/37-45
Storage Class
3 - Flammable liquids
target organs
Eyes
Hazard statements
H225-H301+H311+H331-H370
Hazard Classifications
Acute Tox. 3 DermalAcute Tox. 3 InhalationAcute Tox. 3 OralFlam. Liq. 2STOT SE 1
Precautionary statements
P210-P260-P280-P301+P310-P311

Chemistry & industry

Pharmacology

ATC Code · 4 items

R - Respiratory system

D - Dermatologicals

QD - Dermatologicals

QR - Respiratory system

PharmacodynamicsPheniramine acts as an antagonist to allergic symptoms stemming from inappropriate histamine release to reduce edema, itching, and redness. The same antihistamine effect also produces sedation by acting in the central nervous system.
Mechanism of Action · 1 item

Pheniramine competes with histamine for the histamine H1 receptor, acting as an inverse agonist once bound. The reduction in H1 receptor activity is responsible for reduced itching as well as reduced vasodilation and capillary leakage leading to less redness and edema. This can be seen in the suppression of the histamine-induced wheal (swelling) and flare (vasodilation) response. Inverse agonism of the H1 receptor in the CNS is also responsible for the sedation produced by first-generation antihistamines like pheniramine. The binding of pheniramine to H4 receptors, and subsequent inverse agonism, may also contribute to reduced itching by antagonizing inflammation.

Biological Half-LifeThe terminal half-life of pheniramine administered via IV is 8-17 h.
Metabolism/MetabolitesPheniramine undergoes N-dealkylation to N-didesmethylpheniramine and N-desmethylpheniramine.
MeSH Pharmacological Classification · 3 items

Agents, usually topical, that relieve itching (pruritus).

Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood.

Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475)

Absorption, Distribution and Excretion · 2 items

The administration of 30.5 mg of free base pheniramine resulted in a Cmax of 173-294 ng/mL with a Tmax of 1-2.5 h.

Pheniramine is eliminated by metabolism and via renal excretion. 24.3% of pheniramine is present in the urine as the parent drug.

Cellular LocationsMembrane
Metabolite PathwaysPheniramine H1-Antihistamine Action

Uses & manufacturing

Use Classification · 2 items

Pharmaceuticals -> Dermatologicals -> Antihistamines

Pharmaceuticals -> Animal Drugs -> Approved in Taiwan

Applications

UsesPheniramine is an antigripal drug. Also, it is derived from 2-Benzylpyridine (B288740), which is a benzylpyridine with antifungal properties. 2-Benzylpyridine is also used as a chromogenic reagent for micro determination of Molybednum.

Upstream & downstream products

Upstream raw materials

Potassium amide2-BenzylpyridineMaleic acid

Additional notes

DefinitionChEBI: N,N-dimethyl-3-phenyl-3-(2-pyridinyl)-1-propanamine is a tertiary amino compound and a member of pyridines.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes